Agfa HealthCare announced the release a new version of its Enterprise Imaging for Cardiology platform at the American College of Cardiology ACC.17 expo, March 17-19 in Washington, D.C. Customer-driven enhancements include new structured reporting modules for congenital echocardiology and nuclear cardiology.
March 20, 2017 — Cardiologists can now access the advanced ultrasound imaging technology needed for fast and confident ...
UnityPoint Health – Meriter (Madison, Wis.) recently installed two Carestream DRX-Evolution Plus systems as part of an upgrade designed to enhance and expedite diagnostic imaging for orthopedic and general radiology patients at the 448-bed hospital.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#98667) ...
The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine demonstrates that the positron emission tomography (PET) radiotracer fluciclovine (fluorine-18; F-18) can help guide and monitor targeted treatment for recurrent prostate cancer, allowing for individualized, targeted therapy.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Solis Mammography recently released a statement taking issue with incorrectly interpreted terminology used by reporters and others referring to a mammogram callback as a “false positive.” As evidence, the statement highlighted a study published Feb. 9 in the journal Cancer Epidemiology, Biomarkers & Prevention that referred to mammography recalls as false positive mammograms. This led to news reports across the country stating that a false positive was defined as “a doctor telling a woman that cancer is present, but it turns out not to be.” Solis Mammography said this is more than a simple misspeak on the part of a reporter. It’s a common misunderstanding and is blatantly false.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
March 16, 2017 — MedyMatch Technology announced a collaboration with IBM Watson Health to bring MedyMatch’s artificial ...
During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in Washington, D.C., Siemens Healthineers will showcase technologies that integrate images and information at every step of the treatment process, with a theme of “Making Complex Simple.”
Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las Vegas, where the company will provide a demo of its AccuDetect Computer-Aided Detection (CAD) for Mammography.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Researchers at the University of California Irvine now have access to Toshiba Medical’s most advanced magnetic resonance (MR) technology for their cutting-edge neurology work investigating cerebral microbleeds (CMB) in high school football players as a potential precursor to chronic traumatic encephalopathy (CTE). As part of its ongoing, first-of-its-kind study to identify early signs of brain trauma in young athletes, UCI doctors will now leverage Toshiba Medical’s Vantage Galan 3T MR system as a key diagnostic tool.
March 15, 2017 — Scientists at University College London (UCL) have developed a way to use magnetic resonance imaging ...
CAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative radiation therapy (IORT) using the Xoft Axxent Electronic Brachytherapy (eBx) System. The Xoft System and its suite of products were showcased in the Xoft booth during Physicians’ Education Resource (PER)’s 34th Annual Miami Breast Cancer Conference at the Fontainebleau Miami Beach Hotel in Miami Beach, Fla., March 9-12, 2017.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
A new study in the journal Chest determined that a structured prescreening counseling and shared decision-making visit with healthcare professionals leads to a better understanding of the benefits and risks of low-dose computed tomography (CT) lung cancer screening. The study found this also improved understanding of the eligibility criteria.
The U.S. Food and Drug Administration (FDA) has cleared the Artis pheno robotic C-arm angiography system from Siemens Healthineers created for use in minimally invasive interventional procedures.
International medical imaging IT and cybersecurity company Sectra has signed a ten-year contract with Isala Hospital, in the Netherlands. The contract comprises Sectra’s information technology (IT) solution for reviewing diagnostic images. The solution enables physicians at Isala Hospital to access and review medical images from any of its two hospitals, regardless of where current and prior images were taken. The joint solution also enables the two sites to efficiently share resources.
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to three individuals during its 2017 Annual Scientific Meeting, March 4-9 in Washington, D.C. These awards acknowledge distinguished and extraordinary service to SIR or to the discipline of interventional radiology.
Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer a heart attack or other adverse cardiovascular event, according to a new study appearing online in the journal Radiology.
March 14, 2017 — Over half of older women with early stage breast cancer received more radiation therapy than what might ...
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new solutions for biopsy workflow, at the European Congress of Radiology (ECR) in Vienna, Austria, March 1-5. The company also hosted a symposium and several educational workshops throughout the show, giving attendees opportunities to experience screening and interventional products that offer unique patient and user benefits and address workflow challenges.
FDG positron emission tomography/computed tomography (PET/CT) is a valuable imaging tool for treatment assessment of patients with lung cancer, though systematic evidence for its comparative effectiveness with conventional imaging, such as chest CT, is still evolving, according to a new study.